Alex Davis
Director, Brand Strategy Biosimilars | Organon
Alex Davissecurehost2025-05-02T14:35:14+00:00
APRIL 2025
In this DHCG Disruptive Dose, Mark Bard speaks with Alex Davis, Director of Brand Strategy Biosimilars at Organon about transforming healthcare marketing through a consumer-first lens. With an unconventional background in film and advertising, Davis brings fresh perspectives from working with brands like the US Army and consumer packaged goods to pharma marketing. She challenges the industry’s “direct to patient” terminology, advocating instead for “human centricity” that meets people where they naturally spend their time—particularly on social media and with content creators. Davis emphasizes the importance of building trust through above-brand experiences. The conversation highlights how collaborative relationships with regulatory teams enable authentic storytelling in campaigns, moving beyond formulaic “talk to your doctor” messaging to create distinctive brand narratives that actually resonate with people’s lives.